Home Cart 0 Sign in  
X

[ CAS No. 2604-39-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2604-39-9
Chemical Structure| 2604-39-9
Chemical Structure| 2604-39-9
Structure of 2604-39-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2604-39-9 ]

Related Doc. of [ 2604-39-9 ]

Alternatived Products of [ 2604-39-9 ]

Product Details of [ 2604-39-9 ]

CAS No. :2604-39-9 MDL No. :MFCD09033797
Formula : C5H4ClN3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :YKWBEPUOVBMENG-UHFFFAOYSA-N
M.W : 173.56 Pubchem ID :10910058
Synonyms :

Calculated chemistry of [ 2604-39-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.47
TPSA : 84.73 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.91
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.23
Log Po/w (MLOGP) : -0.7
Log Po/w (SILICOS-IT) : -0.77
Consensus Log Po/w : 0.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.2
Solubility : 1.08 mg/ml ; 0.00624 mol/l
Class : Soluble
Log S (Ali) : -2.9
Solubility : 0.22 mg/ml ; 0.00127 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.66
Solubility : 3.81 mg/ml ; 0.0219 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.15

Safety of [ 2604-39-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2604-39-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2604-39-9 ]
  • Downstream synthetic route of [ 2604-39-9 ]

[ 2604-39-9 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 2604-39-9 ]
  • [ 89182-17-2 ]
YieldReaction ConditionsOperation in experiment
100% With hydrogen In ethyl acetate at 20℃; for 2 h; step 1 : To a solution of 2-chloro-5-nitropyridin-4-amine (4.50 g, 25.93 mmol) in EtOAc (100 mL) was added Raney nickel (0.45 g) followed by stirring under hydrogen at RT for 2 h. The reaction mixture was filtered and the filtrate concentrated under reduced pressure to afford 4.00 g (ca. 100percent) of crude 6- chloropyridine-3,4-diamine as yellow oil. MS (ESI): m/z = 144.3 [M+l]+.
Reference: [1] Patent: WO2013/92940, 2013, A1, . Location in patent: Page/Page column 54
[2] Patent: EP2017277, 2009, A1, . Location in patent: Page/Page column 29
  • 2
  • [ 2604-39-9 ]
  • [ 2586-99-4 ]
Reference: [1] Patent: US2004/116466, 2004, A1,
[2] Roczniki Chemii, 1956, vol. 30, p. 1139,1145[3] Chem.Abstr., <1957> 12089,
[4] Journal of Heterocyclic Chemistry, 1965, vol. 2, p. 196,200
  • 3
  • [ 14432-13-4 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 20 - 100℃; for 1 h;
Stage #2: With ammonia In water at 20℃;
2-ChloiO-4-nitroaminopyridine (10.0 g, mol) was carefully dissolved in 100 mL of concentrated sulfuric acid at room temperature and heated 100 0C for Ih. After the solution was cooled to room temperature, it was poured onto 250 g of crushed ice and treated with concentrated ammonium hydroxide until pH was reached at 3 while the temperature was kept below 200C with ice bath. The yellow solid was separated and extracted with ethyl acetate (200 ml x 3) from aqueous layer. The collected organic layer was concentrated and the residue was purified with silica gel column chromatography (hexane: EtOAc = 4: 1 to EtOAc v/v) to give 6.0 g of 4-Amino-2-chloro-3-nitropyridine in 70 percent yield and 2.0 g of 4-amino-2- Chloro-5-nitropyridine in 25 percent yield. 4-Amino-2-chloro-3-nitropyridine: mp 179-181 °C; UV (H2O) λmax 238.0 (ε 13586, pH 11), 1H-NMR (DMSO, 500 MHz) δ 7.91 (d, J= 6.0, IH), 7.37 (s, 2H), 6.83 (d, J = 6.0, IH); 13C-NMR (DMSO, 125 MHz) δ 149.54, 149.24, 142.69, 142.33, 122.45; 4-amino-2-chloro-5-nitropyridine: 1H-NMR (DMSO, 500 MHz) δ 8.85 (s, IH), 7.37 (s, 2H), 6.96 (s, IH).
Reference: [1] Patent: WO2007/47793, 2007, A2, . Location in patent: Page/Page column 87
[2] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[3] Chem.Abstr., 1957, p. 12089
[4] Nucleosides, nucleotides and nucleic acids, 2004, vol. 23, # 1-2, p. 67 - 76
[5] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
  • 4
  • [ 4487-56-3 ]
  • [ 2604-39-9 ]
YieldReaction ConditionsOperation in experiment
86% With ammonia In methanol at 25 - 28℃; for 18 h; A solution of 2,4-dichloro-5-nitropyridine (3 g, 15 mmol) in methanolic ammonia (15 mL) was stirred at 25-28°C for 18 h. The reaction mixture was concentrated by evaporation in vacuo, then the residue was isolated by filtration and purified by hexane wash (3 x 30 mL), to provide the title compound (2.3 g, 86percent) as a yellow solid. H (400MHz, DMSO-d6) 8.83 (s, 1H), 7.35 (br s, 2H), 7.03 (s, 1H). LCMS (ES+) 173.95 (M+H), RT 1.46 minutes.
Reference: [1] Patent: WO2015/86519, 2015, A1, . Location in patent: Page/Page column 87
  • 5
  • [ 14432-12-3 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Patent: WO2006/84281, 2006, A1, . Location in patent: Page/Page column 187
[2] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
[3] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
[4] Patent: CN103819398, 2016, B, . Location in patent: Paragraph 0030-0038
[5] European Journal of Medicinal Chemistry, 2018, vol. 156, p. 240 - 251
  • 6
  • [ 14432-12-3 ]
  • [ 2604-39-9 ]
YieldReaction ConditionsOperation in experiment
8.89% at 0 - 100℃; for 2.5 h; To a solution of 2-chloropyridin-4-amine (10 g, 78 mmol) in conc. sulfuric acid (60 mL) at 0° C. was slowly added fuming nitric acid (30 mL).
Then reaction mixture was stirred for 30 min.
The reaction mixture was slowly poured into ice; the pH was adjusted to ˜3 with using ammonia solution.
The resultant white solid was isolated via filtration.
The solid was dissolved in conc. sulfuric acid, then heated to 100° C. for 2 h.
The reaction mixture was cooled to room temperature and poured into ice.
The aqueous solution was adjusted to pH ˜3 using ammonia solution; then was extracted with ethyl acetate.
The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure.
The resultant residue was purified by silica gel chromatography using 30percent ethyl acetate in Pet-ether to afford 2-chloro-5-nitropyridin-4-amine (1.2 g, 6.91 mmol, 8.89percent yield) and 2-chloro-3-nitropyridin-4-amine (6 g, 34.6 mmol, 44.4percent yield) as yellow solids. 1H NMR (400 MHz, DMSO-d6): δ ppm 7.90 (d, J=5.77 Hz, 1H) 7.34 (br. s., 2H) 6.83 (s, 1H). MS: MS m/z 172.2 (M+-1).
Reference: [1] Patent: US9643999, 2017, B2, . Location in patent: Page/Page column 80; 81
[2] Nucleosides, nucleotides and nucleic acids, 2004, vol. 23, # 1-2, p. 67 - 76
[3] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[4] Chem.Abstr., 1957, p. 12089
[5] Patent: US2014/127156, 2014, A1, . Location in patent: Page/Page column
  • 7
  • [ 14432-13-4 ]
  • [ 2604-39-9 ]
Reference: [1] Patent: WO2006/50506, 2006, A1, . Location in patent: Page/Page column 116
[2] Patent: EP2017277, 2009, A1, . Location in patent: Page/Page column 31
  • 8
  • [ 4548-45-2 ]
  • [ 2604-39-9 ]
  • [ 27048-04-0 ]
Reference: [1] Chemical Communications, 1998, # 15, p. 1519 - 1520
  • 9
  • [ 109-09-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 10
  • [ 2402-95-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 11
  • [ 14432-16-7 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 12
  • [ 4548-45-2 ]
  • [ 4214-76-0 ]
  • [ 2604-39-9 ]
  • [ 5418-51-9 ]
  • [ 27048-04-0 ]
Reference: [1] Journal of Organic Chemistry, 1985, vol. 50, # 4, p. 484 - 487
[2] Journal of Organic Chemistry, 1985, vol. 50, # 4, p. 484 - 487
  • 13
  • [ 14432-13-4 ]
  • [ 7664-93-9 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[2] Chem.Abstr., 1957, p. 12089
  • 14
  • [ 14432-13-4 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 20 - 100℃; for 1 h;
Stage #2: With ammonia In water at 20℃;
2-ChloiO-4-nitroaminopyridine (10.0 g, mol) was carefully dissolved in 100 mL of concentrated sulfuric acid at room temperature and heated 100 0C for Ih. After the solution was cooled to room temperature, it was poured onto 250 g of crushed ice and treated with concentrated ammonium hydroxide until pH was reached at 3 while the temperature was kept below 200C with ice bath. The yellow solid was separated and extracted with ethyl acetate (200 ml x 3) from aqueous layer. The collected organic layer was concentrated and the residue was purified with silica gel column chromatography (hexane: EtOAc = 4: 1 to EtOAc v/v) to give 6.0 g of 4-Amino-2-chloro-3-nitropyridine in 70 percent yield and 2.0 g of 4-amino-2- Chloro-5-nitropyridine in 25 percent yield. 4-Amino-2-chloro-3-nitropyridine: mp 179-181 °C; UV (H2O) λmax 238.0 (ε 13586, pH 11), 1H-NMR (DMSO, 500 MHz) δ 7.91 (d, J= 6.0, IH), 7.37 (s, 2H), 6.83 (d, J = 6.0, IH); 13C-NMR (DMSO, 125 MHz) δ 149.54, 149.24, 142.69, 142.33, 122.45; 4-amino-2-chloro-5-nitropyridine: 1H-NMR (DMSO, 500 MHz) δ 8.85 (s, IH), 7.37 (s, 2H), 6.96 (s, IH).
Reference: [1] Patent: WO2007/47793, 2007, A2, . Location in patent: Page/Page column 87
[2] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[3] Chem.Abstr., 1957, p. 12089
[4] Nucleosides, nucleotides and nucleic acids, 2004, vol. 23, # 1-2, p. 67 - 76
[5] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
  • 15
  • [ 14432-12-3 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Patent: WO2006/84281, 2006, A1, . Location in patent: Page/Page column 187
[2] Organic and Biomolecular Chemistry, 2013, vol. 11, # 38, p. 6526 - 6545
[3] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
[4] Patent: CN103819398, 2016, B, . Location in patent: Paragraph 0030-0038
[5] European Journal of Medicinal Chemistry, 2018, vol. 156, p. 240 - 251
  • 16
  • [ 109-09-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 17
  • [ 2402-95-1 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 18
  • [ 14432-16-7 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 5941 - 5952
  • 19
  • [ 14432-13-4 ]
  • [ 7664-93-9 ]
  • [ 2604-39-9 ]
  • [ 2789-25-5 ]
Reference: [1] Roczniki Chemii, 1956, vol. 30, p. 1139,1144[2] Chem.Abstr., 1957, p. 12089
  • 20
  • [ 4548-45-2 ]
  • [ 2604-39-9 ]
  • [ 27048-04-0 ]
Reference: [1] Chemical Communications, 1998, # 15, p. 1519 - 1520
  • 21
  • [ 4548-45-2 ]
  • [ 4214-76-0 ]
  • [ 2604-39-9 ]
  • [ 5418-51-9 ]
  • [ 27048-04-0 ]
Reference: [1] Journal of Organic Chemistry, 1985, vol. 50, # 4, p. 484 - 487
[2] Journal of Organic Chemistry, 1985, vol. 50, # 4, p. 484 - 487
  • 22
  • [ 2604-39-9 ]
  • [ 122-51-0 ]
  • [ 2589-11-9 ]
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 31, p. 4054 - 4057
  • 23
  • [ 64-18-6 ]
  • [ 2604-39-9 ]
  • [ 2589-11-9 ]
Reference: [1] Synlett, 2010, # 18, p. 2759 - 2764
  • 24
  • [ 2604-39-9 ]
  • [ 1268521-33-0 ]
YieldReaction ConditionsOperation in experiment
580 mg at 60℃; for 4 h; NBS (564 mg, 3.17 mmol) was added to a solution of 1 (500 mg, 2.88 mmol) in 8 mL of AcOH. The resulting mixture was stirred at 60 °C for 4 h. After cooled to room temperature, the mixture was diluted with water. The precipitate was collected by filtration to afford 580 mg of 2 as a yellow solid, which was used in the next step without further purification. [M+Hj : 251.91, 253.96.
Reference: [1] Patent: WO2018/213211, 2018, A1, . Location in patent: Paragraph 0229; 0230; 0231
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2604-39-9 ]

Chlorides

Chemical Structure| 4548-45-2

[ 4548-45-2 ]

2-Chloro-5-nitropyridine

Similarity: 0.87

Chemical Structure| 23056-36-2

[ 23056-36-2 ]

2-Chloro-4-nitropyridine

Similarity: 0.86

Chemical Structure| 22280-60-0

[ 22280-60-0 ]

6-Chloro-2-methyl-3-nitropyridine

Similarity: 0.84

Chemical Structure| 1268521-33-0

[ 1268521-33-0 ]

3-Bromo-2-chloro-5-nitropyridin-4-amine

Similarity: 0.80

Chemical Structure| 4487-56-3

[ 4487-56-3 ]

2,4-Dichloro-5-nitropyridine

Similarity: 0.78

Amines

Chemical Structure| 1268521-33-0

[ 1268521-33-0 ]

3-Bromo-2-chloro-5-nitropyridin-4-amine

Similarity: 0.80

Chemical Structure| 2586-99-4

[ 2586-99-4 ]

5-Nitropyridine-2,4-diamine

Similarity: 0.78

Chemical Structure| 2789-25-5

[ 2789-25-5 ]

2-Chloro-3-nitropyridin-4-amine

Similarity: 0.76

Chemical Structure| 89284-28-6

[ 89284-28-6 ]

3-Chloro-5-nitropyridin-4-amine

Similarity: 0.74

Chemical Structure| 84487-15-0

[ 84487-15-0 ]

2-Bromo-5-nitropyridin-4-amine

Similarity: 0.72

Nitroes

Chemical Structure| 4548-45-2

[ 4548-45-2 ]

2-Chloro-5-nitropyridine

Similarity: 0.87

Chemical Structure| 23056-36-2

[ 23056-36-2 ]

2-Chloro-4-nitropyridine

Similarity: 0.86

Chemical Structure| 22280-60-0

[ 22280-60-0 ]

6-Chloro-2-methyl-3-nitropyridine

Similarity: 0.84

Chemical Structure| 1268521-33-0

[ 1268521-33-0 ]

3-Bromo-2-chloro-5-nitropyridin-4-amine

Similarity: 0.80

Chemical Structure| 2578-45-2

[ 2578-45-2 ]

2-Chloro-3,5-dinitropyridine

Similarity: 0.79

Related Parent Nucleus of
[ 2604-39-9 ]

Pyridines

Chemical Structure| 4548-45-2

[ 4548-45-2 ]

2-Chloro-5-nitropyridine

Similarity: 0.87

Chemical Structure| 23056-36-2

[ 23056-36-2 ]

2-Chloro-4-nitropyridine

Similarity: 0.86

Chemical Structure| 22280-60-0

[ 22280-60-0 ]

6-Chloro-2-methyl-3-nitropyridine

Similarity: 0.84

Chemical Structure| 1268521-33-0

[ 1268521-33-0 ]

3-Bromo-2-chloro-5-nitropyridin-4-amine

Similarity: 0.80

Chemical Structure| 2578-45-2

[ 2578-45-2 ]

2-Chloro-3,5-dinitropyridine

Similarity: 0.79